What 23 Analyst Ratings Have To Say About Eli Lilly
Portfolio Pulse from Benzinga Insights
Eli Lilly (NYSE:LLY) has received 23 analyst ratings in the last quarter, with 5 being bullish, 16 somewhat bullish, and 2 indifferent. The average 12-month price target for the company is $598.61, an increase of 16.98% from the previous average of $511.71.
October 20, 2023 | 9:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Eli Lilly has received mostly positive analyst ratings, which could boost investor confidence and potentially drive the stock price up.
Analyst ratings often influence investor sentiment. In this case, the majority of the 23 ratings for Eli Lilly are bullish or somewhat bullish, which indicates a positive outlook for the company. This could lead to increased investor confidence and a potential rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100